These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1926632)

  • 1. [Mometasone furoate].
    Veien NK
    Ugeskr Laeger; 1991 Sep; 153(40):2848-50. PubMed ID: 1926632
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of degradation products of mometasone furoate.
    Sahasranaman S; Issar M; Tóth G; Horváth G; Hochhaus G
    Pharmazie; 2004 May; 59(5):367-73. PubMed ID: 15212303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mometasone furoate for vulvar lichen sclerosus.
    Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
    J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mometason furoate levels.
    Lipworth BJ
    Chest; 2001 Sep; 120(3):1034-5. PubMed ID: 11555548
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
    Affrime MB; Banfield C; Nolop K
    Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology.
    Derendorf H; Daley-Yates PT; Pierre LN; Efthimiou J
    Eur Respir J; 2001 Jan; 17(1):157-8. PubMed ID: 11307748
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy.
    Hochhaus G
    Clin Ther; 2008 Jan; 30(1):1-13. PubMed ID: 18343239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual rearrangement product formed during production of mometasone furoate (Sch 32088).
    Puar MS; Thompson PA; Ruggeri M; Beiner D; McPhail AT
    Steroids; 1995 Sep; 60(9):612-4. PubMed ID: 8545849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of mometasone furoate.
    Neher A; Gstöttner M; Scholtz A; Nagl M
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):519-21. PubMed ID: 18490574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of mometasone furoate nasal spray in seasonal allergic rhinitis. First experiences in practice after the introduction of the drug in Hungary].
    Farkas H; Pintér J; Kalabay L; Jakab L; Visy B; Fekete B
    Orv Hetil; 2002 Aug; 143(33):1929-33. PubMed ID: 12244656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate.
    Mirshahpanah P; Döcke WD; Merbold U; Asadullah K; Röse L; Schäcke H; Zollner TM
    Exp Dermatol; 2007 Sep; 16(9):753-61. PubMed ID: 17697148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis as a tool to determine the skin concentration of mometason furoate in rats.
    Gao Q; Zhao Y; Yu J; Yang T; Ding P
    Pharmazie; 2014 Nov; 69(11):787-91. PubMed ID: 25985571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is mometasone furoate aqueous nasal spray (MFNS) effective in reducing symptoms in acute recurrent sinusitis?
    McConaghy JR
    J Fam Pract; 2001 Feb; 50(2):107. PubMed ID: 11219553
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study.
    Aguirre JM; Bagán JV; Rodriguez C; Jimenez Y; Martínez-Conde R; Díaz de Rojas F; Ponte A
    J Oral Pathol Med; 2004 Aug; 33(7):381-5. PubMed ID: 15250828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three nasal topical steroids in the intraocular pressure compartment.
    Bross-Soriano D; Hanenberg-Milver C; Schimelmitz-Idi J; Arrieta-Gomez JR; Astorga del Toro R; Bravo-Escobar G
    Otolaryngol Head Neck Surg; 2004 Feb; 130(2):187-91. PubMed ID: 14990914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activity of inhaled mometasone furoate in allergic mice.
    Chapman RW; Sehring SJ; Garlisi CG; Falcone A; Kung TT; Stelts D; Minnicozzi M; Jones H; Umland S; Egan RW; Kreutner W
    Arzneimittelforschung; 1998 Apr; 48(4):384-91. PubMed ID: 9608881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone--a new topical steroid.
    Med Lett Drugs Ther; 1987 Oct; 29(751):96-8. PubMed ID: 3670213
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical mometasone furoate for phimosis.
    Khope S
    Indian Pediatr; 2010 Mar; 47(3):282. PubMed ID: 20371899
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of mometasone furoate on nasal congestion model in rats.
    Ogawa M; Tsumuro T; Takubo M; Ueda Y; Yatsuzuka R; Kishi Y; Kamei C
    Pharmacology; 2009; 84(2):99-103. PubMed ID: 19602913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.